Abstract
Crasnitin 1 (L-asparaginase) is a new therapeutic agent in the treatment of acute lymphoblastic leukemia. In the development of new drugs thorough toxicological investigations are always carried out and this applied also to Crasnitin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer-Verlag Berlin • Heidelberg
About this chapter
Cite this chapter
Lorke, D., Tettenborn, D. (1970). Experimental Studies on the Toxicity of Crasnitin in Animals. In: Grundmann, E., Oettgen, H.F. (eds) Experimental and Clinical Effects of L-Asparaginase. Recent Results in Cancer Research, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-99984-0_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-99984-0_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-99986-4
Online ISBN: 978-3-642-99984-0
eBook Packages: Springer Book Archive